Immune Checkpoint Inhibitor Induced Tumor Gene Expression Changes in Murine Syngeneic Colon Cancer Models
Presented by Patrick Fadden, PhD, Research Director, Charles River
A Translational Platform Using Primary Human Immune Cells In Vitro, Syngeneic and Humanized Models in vivo to support and advance immuno-oncology drug discovery
Presented by Martin O'Rourke, PhD, Senior Director, Charles River